Th1 and enhance Th2 development (16) . Despite these results that suggest that vitamin A biases the response in a Th2 direction, the influence of RA on allergic disease is limited and appears contradictory. For instance, supplementation with a natural source of vitamin A had a protective effect against exercise-induced asthma in some patients (17) . Several epidemiological studies suggested that vitamin A intake had no association with or protective effect on asthma (18) . In contrast, RA can induce eosinophilia and exacerbation of asthma under certain conditions (19) . Therefore, it is of paramount importance to clarify the regulation of immune responses by RA and its underlying cellular and molecular mechanisms.
The direct effect of RA on allergic inflammatory cells, especially eosinophils, is less well understood. In the present study, we investigated the functional roles of RA on purified human eosinophils. We found that peripheral blood eosinophils expressed receptors for RAs and, interestingly, ATRA and 9-cis-RA dramatically inhibited spontaneous eosinophil apoptosis. The effect exerted by RA was parallel with the down-regulation of caspase 3 transcription and its enzymatic activity. Together, our experiments showed that RAs activated eosinophils to produce several proinflammatory cytokines. were purchased from BioMol Research Laboratories. RXR agonist HX630 was a gift from Dr. H. Kagechika (University of Tokyo, Japan) (20) . All retinoids were dissolved in DMSO (Sigma-Aldrich) at 5-25 mM stock solutions, protected from light, and stored at Ϫ70°C.
Materials and Methods

Cell preparation
Peripheral venous blood was obtained from subjects with mild eosinophilia. Informed consent was obtained from each subject, and the study protocol was approved by the Ethics Committee of Akita University School of Medicine. Eosinophils were isolated by sedimentation with 6% dextran followed by centrifugation on 1.088 Percoll (Pharmacia) density gradients (21, 22) . The cells were further purified by negative selection using anti-CD16 immunomagnetic beads and a MACS system (Miltenyi Biotec). The eosinophils (Ͼ98% purity) were then suspended in HBSS with 1% FCS in tubes coated with 3% human serum albumin. Mononuclear cells were isolated from peripheral venous blood by Ficoll-Paque (Pharmacia) density gradient centrifugation. The cells were washed twice in cold PBS and monocytes were purified using a MACS system according to the manufacturer's instructions.
RT-PCR
Total RNA was extracted with the use of Ultraspec RNA (Biotex Laboratories) from eosinophils. The total RNA was reverse transcribed with 3 g of RNA using an Omniscript reverse transcriptase (RT) kit (Qiagen) according to the manufacturer's protocol. One microliter of the cDNA synthesis reaction was used as a template for PCR amplification with AmpliTaq DNA polymerase (PerkinElmer). The sequences of the 5Ј sense primers and the 3Ј antisense primers synthesized based on published sequence data (23) and used in this study were as follows: RAR␣, 5Ј-TGGGTGGACTCTCCCCGCCA-3Ј (sense) and 5Ј-CCCACCTCCGGC GTCAGCGTG-3Ј (antisense) (product size 438bp); RAR␤, 5Ј-CACTG GCTTGACCATCGCAGACC-3Ј (sense) and 5Ј-GAGAGGTGGCATTG ATCCAGG-3Ј (anti-sense) (product size 400bp); RAR␥, 5Ј-GGCC TGGGCCAGCCTGACCTC-3Ј (sense) and 5Ј-CAGCCCCAGATCCA GCTGCACG-3Ј (antisense) (product size 537 bp); RXR␣, 5Ј-ATG GCTGCCCCCTCGCTGCAC-3Ј (sense) and 5Ј-GGCGCAGATGTG CTTGGTG-3Ј (antisense) (product size 327 bp); RXR␤, 5Ј-ATGCCACC CCCGCCACTGGGC-3Ј (sense) and 5Ј-GCCTCCAGGATCCTGTC CACAGGC-3Ј (antisense) (product size 552 bp); and RXR␥, 5Ј-CCCC TGGTCACACTGGCTCGACG-3Ј
(sense) and 5Ј-CACCAG AGACCCAGGGCTGGTGG-3Ј (anti-sense) (product size 351 bp). The PCR cycle consisted of 45-s denaturation at 94°C; 45-s annealing at 60°C (RAR␤, RXR␥, ␤-actin), 62°C (RXR␤), and 64°C (RAR␣, RAR␥, RXR␣); and 1-min extension at 72°C for 30 -35 cycles. The PCR products were separated by electrophoresis on a 12.5% PhastGel and the gel was stained using a PhastGel DNA Silver Staining Kit (Amersham Pharmacia Biotech).
Immunoblotting
Eosinophils or monocytes (2 ϫ 10 6 cells) were lysed in a lysis buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM Na 3 VO 4 , 1 mM NaF, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 1% Triton X-100, 10% glycerol, 1 mg/ml aprotinin, leupeptin, and pepstatin). After 20 min on ice, detergentinsoluble materials were removed by centrifugation at 4°C at 12,000 ϫ g. The supernatants were mixed with SDS sample buffer and boiled for 4 min. SDS-polyacrylamide (10%) gels (Ready Gel J) were obtained from BioRad. The electrophoresed gel was blotted onto Hybond ECL membranes (Amersham). Excess binding sites were blocked by incubation with 10% BSA in TBS-T buffer (20 mM Tris-HCl, 137 mM NaCl, and 0.05% Tween 20, pH7.6) for 1 h followed by incubation in the primary Ab overnight at 4°C (rabbit polyclonal anti-RAR␣, ␤, or ␥ and RXR␣, ␤, or ␥ Abs) from Santa Cruz Biotechnology. After washing three times with TBS-T, the membrane was incubated with the secondary Ab (0.04 mg/ml HRP-conjugated goat anti-rabbit IgG Ab from Santa Cruz Biotechnology) for 30 min. The blots were visualized by an ECL system (Amersham) according to the manufacturer's instructions. 
Flow cytometric analysis for retinoid receptors
Intercellular staining was performed to detect nuclear retinoid receptors in eosinophils using a Fix and Perm Cell Permeabilization Kit (Caltag Laboratories). The purified eosinophils were washed twice with PBS and then stained with 1/500 diluted rabbit polyclonal anti-RAR␣, ␤, or ␥ and RXR␣ or ␤ Abs (Santa Cruz Biotechnology) and PE-conjugated, affinity-purified anti-rabbit IgG (Rockland). Rabbit IgG Ab (DakoCytomation) was used as an isotype-matched control. The stained cells were analyzed using a flow cytometer (FACScan; BD Immunocytometry Systems).
Cell culture
Purified eosinophils were resuspended at 0.5 ϫ 10 6 cells/ml in RPMI 1640 medium (Life Technologies) with 10% FCS and incubated with or without indicated concentrations of 9-cis-RA, ATRA, TTNPB, HX630, 0.1% DMSO (vehicle), IL-5 (Genzyme), or GM-CSF (Genzyme) at 37°C in humidified air with 5% CO 2 for 4 -72 h. In some experiments, eosinophils were preincubated with or without neutralizing anti-IL-5 or anti-GM-CSF Ab (Genzyme). The RPMI 1640 was supplemented with 2 mM L-glutamine, penicillin (100 IU/ml), and streptomycin (100 g/ml). Eosinophils were then examined for each analysis. We confirmed that the effect of DMSO was negligible at the concentration used in each experiment.
Determination of cell death and apoptosis by flow cytometry and morphological analysis
An apoptosis detection kit (Medial Biological Laboratories) was used to quantitatively determine eosinophils undergoing apoptosis by virtue of their ability to bind to annexin V and propidium iodide (PI). Briefly, harvested eosinophils were washed twice in cold PBS and stained with annexin V and PI according to the manufacturer's instructions. Eosinophil apoptosis and viability were analyzed using a BD Biosciences FACScan cytometer (22) . To evaluate apoptosis and nuclear hypersegmentation, cytospins of eosinophils recovered from different cultures were prepared and then stained with Diff-Quick staining. Evidence of apoptotic morphology such as decreased cell size, nuclear condensation, and anucleation was assessed by light microscopy in a blind fashion. Nonapoptotic eosinophils were also assessed for the number of nuclear segmentations. Two hundred eosinophils were counted, and the percentage of eosinophils in each morphological change was calculated.
Microarray hybridization
After incubation with vehicle, 10 Ϫ6 M 9-cis-RA or ATRA in 1% human serum albumin-coated plates, each 4 ϫ 10 6 cells, for 4 h, eosinophils were lysed, and total RNA was isolated using Isogen (Nippon Gene) as per the manufacturer's instructions. RNA was repurified with phenol-chloroform extraction and ethanol precipitation. For each cell culture condition, the total RNA from three donors was pooled, enabling us to acquire adequate amounts of RNA for microarray analysis. RNA quality was assessed using a microcapillary electrophoretic analyzer (Agilent Technologies). The 28S/ 18S rRNA intensity was Ͼ1.4. The gene array procedures were performed at Mitsubishi Kagaku BCL using a protocol described elsewhere (24, 25) . Differences of 747 genes (Genomessage version 2; Japan Genome Solutions) between RAs and vehicle control were determined using ImaGene software (BioDiscovery). The sample and reference amplified sample RNAs were labeled with Cy3-dUTP and Cy5-dUTP (PerkinElmer), respectively, using a SuperScript II kit (Invitrogen) along with random hexamers (TaKaRa). RNA mixture ( DNA, baculovirus glycoprotein gene, and Renilla luciferase gene) employed as external control. Competitive hybridization of Cy3-labeled sample and Cy5-labeled reference cDNA on the microarray was conducted according to a previous report (26) . The Cy3 (treated sample)/Cy5 (reference sample) ratio for each mRNA signal was calculated according to global Lowess normalization (27) . Slides were scanned five times with five different power ranges using a ScanArray 5000 (PerkinElmer). For statistical analysis, the data were converted from tiff image data to signals using ImaGene software (BioDiscovery). The microarray data were deposited in the public Gene Expression Omnibus database (www.ncbi.nlm.nih.gov/geo/) under accession no. GSE12926.
Detection of cytokines in cell culture supernatants
Culture samples were analyzed with a cytokine Ab array by using a RayBio Human Cytokine Ab Array (RayBiotech) according to the manufacturer's instructions. Concentrations of IL-5, IL-8, GM-CSF, vascular endothelial growth factor (VEGF), M-CSF, and MCP-1 were measured using an ELISA kit (R&D Systems), and colorimetric measurements were performed according to the manufacturer's protocol.
RT-PCR confirmation of gene microarray data
For confirmation of expression patterns indicated by microarray analysis, 4 g of total RNA was subjected to first-strand cDNA synthesis as described in Microarray hybridization. RT-minus controls were included for each RT reaction. Primers and TaqMan probes for target genes were purchased from Applied Biosystems TaqMan Gene Expression Assays. Quantification of target cDNA and an internal reference gene (GAPDH) was performed in 96-well plates on the Applied Biosystems PRISM 7700 Sequence Detection System for data collection, and analyses were performed using the machine software. PCR was conducted in a final volume of 25 l containing cDNA equivalent to 10 -100 ng of total RNA, 12.5 l of 1ϫ TaqMan Universal PCR Master Mix, and 1.25 l of 20ϫ TaqMan Expression Assay reagent. Each sample was analyzed in triplicate. Thermal cycler conditions were 50°C for 2 min and 95°C for 10 min, followed by 50 cycles at 95°C 
Measurement of caspase 3 activity
After treatment of eosinophils with 9-cis-RA and ATRA for 18 h, caspase 3 activity in these cells was assayed with an APOPCYTO colorimetric assay kit (MBL) according to the manufacturer's instructions.
Statistical analysis
For comparison of groups, ANOVA was used. If the ANOVA was significant, post hoc pairwise comparisons were conducted using Tukey's test, with the level of statistical significance taken as p Ͻ 0.05. The results are expressed as mean Ϯ SEM.
Results
Retinoid receptor profile of human peripheral blood eosinophils
To provide a baseline for the interpretation of our studies, we first investigated the gene expression of all known RAR subtypes in human peripheral blood eosinophils using RT-PCR. The expression profile was compared with freshly isolated human monocytes. We found that human eosinophils expressed mRNA for all RAR subtypes. In contrast, RAR␤ was undetectable in human monocytes, consistent with a previous report (28) . A similar pattern of RXR mRNA expression was observed between monocytes and eosinophils: RXR␣ and RXR␤, but not RXR␥, were expressed (Fig. 1A) . On the basis of these results, the protein expression of RARs and RXRs on eosinophils was studied. Using Western blotting, we demonstrated that all three RAR isoforms, RXR␣, and RXR␤ were present in the lyses of eosinophils from two different donors (Fig. 1B) . We also confirmed the protein expression by flow cytometry analysis on permeabilized cells. Similarly to the Western blotting, RAR␣, RAR␤, RAR␥, RXR␣, and RXR␤ were expressed in human eosinophil preparations (Fig. 1C) . Because RXR␥ mRNA was not detected by PT-PCR, RXR␥ protein expression was not studied further.
9-cis-RA and ATRA markedly delay eosinophil apoptosis
It has been reported that RAs (10 Ϫ6 M) regulate survival in several types of cells. To investigate the functional role of RAs, we first examined the capacity to modulate eosinophil apoptosis that spontaneously occurs after culturing these cells. Eosinophil apoptosis was determined by flow cytometry; Annexin V was used to stain the early phase apoptotic cells, while PI was used to stain the late phase cells. Purified human blood eosinophils were incubated with the natural ligand for RARs and RXRs (9-cis-RA and ATRA, 10 Ϫ6 M) or vehicle control (0.1% DMSO) for 48 h. The percentage of cells undergoing apoptosis was dramatically decreased in eosinophils incubated with 9-cis-RA or ATRA compared with vehicle control ( Fig. 2A) . 9-cis-RA and ATRA delayed eosinophil apoptosis in a dose-dependent manner and occurred around their physiological concentrations (10 Ϫ9 -10 Ϫ8 M) (Ref. 29 and Fig.  2B ). Of note, their ability to delay apoptosis almost equaled that of IL-5 (1 ng/ml), a critical cytokine mediating eosinophil survival. As shown in Fig. 2C , eosinophils incubated with RAs displayed almost 80% viability at 72 h after incubation (vehicle, 12.0 Ϯ 4.1%; 9-cis-RA, 81.9 Ϯ 3.5%; and ATRA, 78.0 Ϯ 3.8%).
Morphological appearance of eosinophils incubated with RAs
To assess the morphological evidence of apoptosis and cell activation, eosinophils were cultured for 48 h with vehicle alone, IL-5 (1 ng/ml), 9-cis-RA (10 Ϫ6 M), or ATRA (10 Ϫ6 M) and were observed by light microscopy (Fig. 3) . Reflecting spontaneous apoptosis, eosinophils with apoptotic morphology (cytoplasmic and nuclear chromatin condensation, and anucleation) were seen after they were cultured with vehicle alone. In contrast, eosinophils cultured with IL-5, 9-cis-RA, or ATRA avoided apoptotic changes and, interestingly, several nonapoptotic cells had more than three nuclear lobes. Because nuclear hypersegmentation is induced by eosinophiliopoietic cytokines and indicates the increased life span (30) , the number of nuclear segmentations besides apoptotic change was quantified and is shown in Table I . In line with the flow cytometric studies, after culture for 48 h, apoptotic eosinophils were decreased by IL-5 or RAs compared with vehicle alone. Of note, incubation with IL-5 or RAs induced a significant increase in the number of eosinophils with hypersegmented nuclei, while most of the freshly purified peripheral blood eosinophils or vehicle-cultured live eosinophils showed bisegmented nuclei. These data provide multiple lines of evidence demonstrating prolonged survival induced by RAs.
Effect of pharmacological agonists and antagonists on eosinophil survival
To determine which of the two types of RARs is involved in the antiapoptotic effect, we used the specific agonists for each receptor: RAR-selective agonist TTNPB (31) and RXR-selective agonist HX630 (32) . Eosinophils were cultured in the presence of either TTNPB or HX630 for 48 h, and cell viability was assessed by flow cytometry staining with annexin V and PI. Interestingly, both TTNPB and HX630 delayed the eosinophil apoptosis, although HX630 had a less potent effect (Fig. 4A) . The cell viability of vehicle, TTNPB (10 Ϫ6 M), and HX630 (10 Ϫ6 M) was 15.2 Ϯ 5.5%, 73.4 Ϯ 3.4%, and 28.8 Ϯ 5.7%, respectively. These results indicate that both RARs and RXRs (mainly RARs) are involved in the effect of RAs to delay eosinophil apoptosis. Next, we examined the effect of receptor blockade on RA-induced eosinophil survival. As shown in Fig. 4B , pretreatment with RAR␣-specific antagonist Ro41-5253 nearly completely inhibited the effect of ATRA at the (n ϭ 4) . Eosinophil survival was significantly prolonged by culturing with IL-5 (1 ng/ml) or GM-CSF (0.1 ng/ml) and these effects were completely blocked by each neutralizing Ab. In contrast, neutralizing anti-IL-5 or anti-GM-CSF (20 g/ml) Abs failed to reverse the effect of RAs. *, p Ͻ 0.05. concentration of 10 Ϫ5 M (70.1% inhibition). In contrast, the antiapoptotic effect of 9-cis-RA was partially blocked by Ro41-5253 at 10 Ϫ5 M (26.9% inhibition). Therefore, it is suggested that RAR␣ activation is important for RA-induced eosinophil survival, although RXR activation can partially compensate for the effect.
Identification of RA-dependent transcriptional targets by gene microarray
In an attempt to identify genes that are associated with RA-induced eosinophil survival, we next determined the expression levels of eosinophil transcripts using a microarray following stimulation with vehicle, 9-cis-RA (10 Ϫ6 M), or ATRA (10 Ϫ6 M) for 4 h. Additional longer time points were prohibited by the difficulty of obtaining subjects to harvest the required amount of RNA for the microarray. Approximately 444 genes were detected on the chip containing 747 genes (raw data are available at the Gene Expression Omnibus site as cited in Materials and Methods). There was little variation between the samples treated by 9-cis-RA and ATRA. The main results are indicated in Table II . The comparison between vehicle control and 9-cis-RA, or vehicle control and ATRA, identified an increase (Ͼ2-fold change over control) in 19 and 11 transcripts, respectively. The number of decreased transcripts (Ͻ0.5-fold) resulting from 9-cis-RA or ATRA exposure was 19 and 8 transcripts, respectively. In these transcripts, the expression changes relative to vehicle control were smaller in with ATRA compared with 9-cis-RA, suggesting that 9-cis-RA induced gene transcription more effectively than ATRA. Of note, among the 10 genes with the biggest decrease relative to vehicle control, we found an apoptosis-related gene, caspase 3 (9-cis-RA, 0.33-fold decrease and ATRA, 0.39-fold decrease).
RAs induced production of M-CSF, VEGF, and MCP-1, but they were not involved in antiapoptotic effect
RAs affect cytokine, chemokine, and growth factor production from several types of cells. Because of the strong efficacy of RAs and the potential of eosinophil to produce IL-5 and GM-CSF, critical promoters of eosinophil survival (2), we examined whether RAs prolong survival by autocrine production of IL-5 or GM-CSF using neutralizing Abs. However, cotreatment of neutralizing anti-IL-5 or anti-GM-CSF Abs failed to reverse the effect of RAs (Fig.  5) . We also found that IL-3, an eosinophil survival-promoting cytokine (2), was not involved in RA-induced cell survival using a neutralizing anti-IL-3 Ab (n ϭ 3; data not shown). Moreover, neither IL-5 nor GM-CSF in the supernatants of eosinophils cultured with RAs for 24 h was detected by ELISA. These results indicate that the antiapoptotic effect of RAs was not dependent on autocrine production of IL-3, IL-5 or GM-CSF.
To further establish the profiles of cytokine, chemokine, and growth factor release from eosinophils exposed to 9-cis-RA (10 Ϫ6 M) and ATRA (10 Ϫ6 M), Ab arrays were used (Fig. 6) . Among the 23 cytokines and chemokines, a significant amount of IL-8 was detected in the supernatants of the cultured eosinophils. However, the production did not differ from that after stimulation with vehicle and RAs, and this was confirmed by ELISA (vehicle control, 129.1 Ϯ 44.8 pg/ml; 9-cis-RA, 97.1 Ϯ 38.5 pg/ml; and ATRA, 97.7 Ϯ 38.1 pg/ml, each value is not statistically significant, n ϭ 3). Remarkably, we found that both 9-cis-RA and ATRA could activate eosinophils to markedly induce the release of MCP-1. Based on this finding, the MCP-1 concentration was also measured by ELISA, revealing increased secretion in the supernatants by stimulation with 9-cis-RA or ATRA (Table III) . In addition, because the gene microarray data showed increased M-CSF and VEGF expression, secretion of these was measured by ELISA. Consistent with previous report by Horiuchi et al. (33) , IL-5 induced VEGF production. As we expected, M-CSF and VEGF secretion in the supernatants was increased by stimulation with 10 Ϫ6 M 9-cis-RA or ATRA. However, stimulation with each cytokine (100 pg/ml) or combination of them for 24 h did not affect eosinophil survival (vehicle control, 65.1 Ϯ 7.1%; M-CSF, 62.2 Ϯ 7.1%; VEGF, 63.6 Ϯ 7.4%; MCP-1, 65.5 Ϯ 8.5%; and combination of M-CSF, VEGF, and MCP-1, 63.2 Ϯ 8.4%; n ϭ 3). These results indicated that RAs triggered eosinophils to produce M-CSF, VEGF, and MCP-1, but they were not involved in inhibition of spontaneous eosinophil apoptosis. Eosinophils were treated with IL-5 (1 ng/ml), 9-cis-RA (10 Ϫ6 M), or ATRA (10 Ϫ6 M) for 18 h, followed by measurement of caspase 3 activity using a colorimetric assay kit (n ϭ 5-6). ‫,ء‬ p Ͻ 0.05 vs vehicle control (18 h). Caspases, a family of cysteine proteases, are activated in the interior of cells during the process to apoptosis. Among them, caspase 3 is the final effector caspase whose targets include the DNA nuclease responsible for the characteristic nuclear degradation of apoptosis (34) . Because gene microarray data revealed markedly decreased caspase 3 gene expression by RAs, we next confirmed this observation using quantitative real-time RT-PCR. As shown in Fig. 7A , in comparison to the vehicle controls, we found around one-quarter the mRNA levels in RA-stimulated eosinophils. Caspase 3 activity, measured colorimetrically in arbitrary units as the cleavage of the tetrapeptide N-acetyl-Asp-GluVal-Asp-p-nitroanilide (Ac-DEVD-pNA), was increased in eosinophils cultured with vehicle for 18 h. In agreement with the initial description of Zangrilli et al. (35) , IL-5 (1 ng/ml) reduced activation of caspase 3, and we also observed that 9-cis-RA or ATRA reduced caspase 3 activation to nearly the same extent as IL-5 (Fig. 7B) . These results suggested that RAs inhibited caspase 3 expression following enzymatic activity, which resulted in resistance to spontaneous apoptosis.
Discussion
Recent accumulating evidence has indicated the important roles of vitamin A in the immune system, especially Th2-type reactions. In the present study, we report the expression of retinoid receptors in human peripheral blood eosinophils and that RAs strikingly inhibited eosinophil spontaneous apoptosis. This novel activity appears to be associated with down-regulation of caspase 3 and inhibition of its enzymatic activity. Additionally, RAs also activated eosinophils to produce proinflammatory cytokines. To our knowledge, this is the first report indicating the functional existence of vitamin A derivatives on human eosinophils. Our study adds additional information on the potential role of vitamin A in regulating immune responses. Nuclear hormone receptors mediate the important biological function on eosinophils. We previously reported that human eosinophils expressed peroxisome proliferator-activated receptor ␥ (PPAR␥), a heterodimer partner of RXR, and that stimulation of eosinophils with a synthetic PPAR␥ agonist inhibited IL-5-induced eosinophil survival by leading apoptosis (22) . Based on previous reports that the PPAR␥ agonist-induced apoptotic effect was increased by cotreatment with the agonist for RXR (36) or with 9-cis-RA (37), we initially speculated that PPAR␥/RXR activation by each agonist synergistically induced eosinophil apoptosis. However, contrary to our expectation, a preliminary study revealed that cotreatment of eosinophils with 9-cis-RA and a synthetic PPAR␥ agonist prolonged cell survival. In this study, because of the strong efficacy of RAs to inhibit eosinophil apoptosis comparable to that of eosinophiliopoietic cytokines such as IL-3, IL-5, and GM-CSF, we investigated the ability of RAs on eosinophils to trigger antiapoptotic protein secretion in cell culture supernatants, although they were not involved in the effect of RAs. Furthermore, the intracellular expression of Bcl-2 and Bcl-x L , which are involved in the process of cytokine-induced inhibition of eosinophil apoptosis (38) , were not altered by stimulation with 9-cis-RA or ATRA (our unpublished data). Taken together with the pharmacologic manipulations with the specific agonists and antagonists, the evidence could support the hypothesis that RAs directly inhibit eosinophil spontaneous apoptosis through activation of both RARs and RXRs.
Because little is known about the mechanism behind the antiapoptotic effect of activated nuclear hormone receptors on eosinophils, we used a gene microarray to search for RA-responsive antiapoptotic targets. Among the several transcripts responsive to both 9-cis-RA and ATRA, down-regulation of caspase 3 was screened as the most likely candidate responsible for the eosinophil survival-promoting activity. Spontaneous eosinophil apoptosis involves Bax translocation to the mitochondria, cytochrome c release, and perturbation of the mitochondrial membrane followed by activation of caspases (39) . In the case of IL-5-induced eosinophil survival, it is mediated by inhibition of Bax translocation and the consequent activation of the caspase pathway. We were able to show that the inhibition of spontaneous caspase 3 activation was nearly the same extent as that of eosinophiliopoietic cytokine IL-5. Taken together, our data suggest that the caspase 3-mediated spontaneous apoptotic process is, at least in part, involved in RA-induced prolonged eosinophil survival. In contrast, we cannot rule out the possibility that the effects of RAs are mediated by an additional molecular target(s), as indicated in the results from the gene array. For example, peroxiredoxin 6, ranked as the fifth mostincreased transcript both in 9-cis-RA-and ATRA-stimulated eosinophils, uses glutathione to catalyze the reduction of reactive oxygen species and protects from reactive oxygen species-induced cytotoxicity in different cell types (40) . The second most-decreased transcript, fos, is known to be an AP-1 transcription factor and is involved in the regulation of myeloid differentiation (41), but it is not clear whether it also has other effects on human eosinophils. Thus, further studies are necessary to clarify the involvement of these molecules and/or alternative mechanisms, but such studies will definitely provide interesting insights into the physiological importance of RAs and these molecules on eosinophil survival.
RARs are known to be important regulators of granulopoiesis. Dietary vitamin A-deficient mice exhibited abnormal expansion of myeloid cells probably due to impaired spontaneous apoptosis (42) , and mice genetically deficient in both RAR␣ and RAR␥ displayed an in vitro block in granulocyte differentiation (43) . Thus, it is now widely accepted that ATRA is a clinically useful compound that induces terminal granulocyte differentiation and apoptosis of most acute promyelocytic leukemia cells. In addition, retinoids can alter lineage commitment: ATRA suppresses erythroid maturation of normal pluripotent progenitor cells, forcing differentiation toward the neutrophil lineage (44) . It was reported that ATRA inhibited eosinophil differentiation of CD34 ϩ cord blood cells (45) and bone marrow mononuclear cells obtained from the hypereosinophilic syndrome (46) . In line with these observations, previous studies with eosinophil-committed cell lines such as HL-60 (47) and AML14.3D10 (48) have also indicated the inhibition of eosinophil differentiation by RAs. In contrast to these data that point out the inhibition of survival and differentiation in immature eosinophils by RAs, here we clearly demonstrated that RAs prolong survival in terminal differentiated eosinophils in vitro. This effect was quite reproducible, as it was consistently observed using eosinophils from many different donors. One explanation for this difference is that the effect of RAs is cell type specific and could be changed according to the stage of differentiation. The plasma concentration of RAs has been reported to reach 10 Ϫ8 M (29), which is sufficient to stimulate eosinophil survival, as shown in our study; hence, RAs may play a role in the regulation of eosinophil homeostasis.
This work also led us to consider the potential role of RAs in allergic inflammatory diseases, namely, bronchial asthma. The majority of the body's vitamin A is stored in the liver; however, many other organs including the lung have a large concentration of vitamin A (6). Vitamin A derivatives are known to influence the development, maintenance, differentiation, and regeneration of lung epithelial cells (49) ; hence, it may play a central role in the development of airway diseases. Interestingly, Shoseyov et al. (50) showed that asthmatic rats increased vitamin A utilization by repeated allergen inhalation. Furthermore, it was reported that the serum vitamin A concentration in asthmatic patients in both developing and developed countries was significantly lower than that in normal controls (51, 52) . Thus, these studies suggest increased vitamin A utilization in allergic airway inflammation.
Eosinophils contribute to persistent airway inflammation, which leads to airway structural changes called airway remodeling, including subepithelial fibrosis, hyperplasia of mucus glands, myofibroblast and smooth muscle proliferation, and vascular changes (2) . In the course of the screening procedure with a gene microarray and a cytokine array, we discovered that RAs induced VEGF and MCP-1 production in cell culture supernatants. In the asthmatic airway, they are produced in abundance and are thought to be involved in the allergic inflammatory processes by activation of their target cells, especially vascular endothelial cells and monocytes/macrophages (53, 54) . Another intriguing observation was that RAs induced hypersegmentation of eosinophil nuclei, a morphological abnormality often observed in cells from bronchoalveolar lavage fluid in eosinophilic pneumonia (30, 55) . This evidence raises the possibility of RAs as a significant contributor to sustaining the heightened eosinophilic inflammatory response and of antiRARs as a novel therapeutic strategy in asthma and other allergic inflammatory diseases. Efforts are currently under way to clarify the pathophysiological significance of RAs using an in vivo model.
In conclusion, our current data provide novel insights into the roles of vitamin A in eosinophil homeostasis. Physiological levels of RAs have a potent inhibitory effect on eosinophil spontaneous apoptosis and might facilitate sustainment of allergic inflammation. Our finding is potentially of therapeutic importance, as an anti-RAR/RXR strategy would not only be the antiapoptotic effect on eosinophils but also the action of removing the potential role of RA on producing proinflammatory cytokines.
